Literature DB >> 6316163

Isolation and structural organization of the human preproenkephalin B gene.

S Horikawa, T Takai, M Toyosato, H Takahashi, M Noda, H Kakidani, T Kubo, T Hirose, S Inayama, H Hayashida.   

Abstract

The primary structure of porcine preproenkephalin B has been elucidated by cloning and sequencing cDNA: it contains neoendorphin, dynorphin and leumorphin (containing rimorphin as its amino-terminus). These opioid peptides, each having a leucine-enkephalin structure, act on the kappa-receptor. We have now cloned a human genomic DNA segment containing the preproenkephalin B gene. The structural organization of this gene resembles those of the genes encoding the other opioid peptide precursors, that is, preproenkephalin A and the corticotropin-beta-lipotropin precursor (ACTH-beta-LPH precursor). The primary structure of human preproenkephalin B has been deduced from the gene sequence. The amino acid sequence homology observed between preproenkephalin B and preproenkephalin A, together with the similarity between their gene organizations, suggests that the two genes have been generated from a common ancestor by gene duplication.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6316163     DOI: 10.1038/306611a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  40 in total

Review 1.  The dynorphin/κ-opioid receptor system and its role in psychiatric disorders.

Authors:  H A Tejeda; T S Shippenberg; R Henriksson
Journal:  Cell Mol Life Sci       Date:  2011-10-16       Impact factor: 9.261

Review 2.  30 years of dynorphins--new insights on their functions in neuropsychiatric diseases.

Authors:  Christoph Schwarzer
Journal:  Pharmacol Ther       Date:  2009-05-28       Impact factor: 12.310

3.  Protein kinase A-dependent derepression of the human prodynorphin gene via differential binding to an intragenic silencer element.

Authors:  A M Carrión; B Mellström; J R Naranjo
Journal:  Mol Cell Biol       Date:  1998-12       Impact factor: 4.272

Review 4.  Search for genetic markers and functional variants involved in the development of opiate and cocaine addiction and treatment.

Authors:  Vadim Yuferov; Orna Levran; Dmitri Proudnikov; David A Nielsen; Mary Jeanne Kreek
Journal:  Ann N Y Acad Sci       Date:  2010-02       Impact factor: 5.691

5.  Simple human DNA-repeats associated with genomic hypervariability, flanking the genomic retroposons and similar to retroviral sites.

Authors:  E I Rogaev
Journal:  Nucleic Acids Res       Date:  1990-04-11       Impact factor: 16.971

6.  Alcohol dependence, disinhibited behavior and variation in the prodynorphin gene.

Authors:  Janine D Flory; Carolyn L Pytte; Yasmin Hurd; Robert E Ferrell; Stephen B Manuck
Journal:  Biol Psychol       Date:  2011-07-05       Impact factor: 3.251

7.  Correlation of neuronal size and peptide immunoreactivity in the guinea-pig trigeminal ganglion.

Authors:  W Kummer; C Heym
Journal:  Cell Tissue Res       Date:  1986       Impact factor: 5.249

8.  A Huntington disease-like neurodegenerative disorder maps to chromosome 20p.

Authors:  F Xiang; E W Almqvist; M Huq; A Lundin; M R Hayden; L Edström; M Anvret; Z Zhang
Journal:  Am J Hum Genet       Date:  1998-11       Impact factor: 11.025

9.  Distribution of functional significance of Met-enkephalin-Arg6-Phe7- and Met-enkephalin-Arg6-Gly7-Leu8-like peptides in the blowfly Calliphora vomitoria. II. Immunocytochemical mapping of neuronal pathways in the retrocerebral complex and thoracic ganglion.

Authors:  H Duve; A Thorpe
Journal:  Cell Tissue Res       Date:  1990-01       Impact factor: 5.249

10.  A functional haplotype implicated in vulnerability to develop cocaine dependence is associated with reduced PDYN expression in human brain.

Authors:  Vadim Yuferov; Fei Ji; David A Nielsen; Orna Levran; Ann Ho; Susan Morgello; Ruijin Shi; Jurg Ott; Mary Jeanne Kreek
Journal:  Neuropsychopharmacology       Date:  2008-10-15       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.